Competitors of Gland Pharma Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| MPS Pharmaa Ltd | 8.20 Cr. | 4.29 | 4.33/2.79 | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 3,317 Cr. | 304 | 390/147 | 62.9 | 20.5 | 0.22 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 59.8 Cr. | 80.5 | 94.9/26.6 | 22.9 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 33.8 Cr. | 23.0 | 27.0/8.74 | 43.8 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 85.8 Cr. | 114 | 155/87.0 | 12.9 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 12,097 Cr. | 988 | 1,335/647 | 28.6 | 207 | 2.28 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 358 Cr. | 15.8 | 29.0/13.2 | 20.7 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 9.01 Cr. | 18.6 | 27.1/15.0 | 180 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 349 Cr. | 742 | 1,054/650 | 19.7 | 278 | 0.09 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 64.8 Cr. | 21.6 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,092 Cr. | 371 | 440/145 | 133 | 98.6 | 0.34 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.52 Cr. | 31.0 | 43.8/23.6 | 130 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.7 Cr. | 7.90 | 19.4/7.17 | 43.7 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 241 Cr. | 301 | 301/110 | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 189 Cr. | 2.03 | 3.03/1.03 | 255 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 28.6 Cr. | 11.9 | 14.5/6.40 | 34.5 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.5 Cr. | 15.4 | 25.8/14.4 | 18.7 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 275 Cr. | 772 | 999/345 | 11.8 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.1 Cr. | 37.1 | 61.5/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 31.2 Cr. | 68.3 | 84.4/36.0 | 56.8 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 10.0 Cr. | 4.02 | 26.5/4.02 | 40.2 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.6 Cr. | 111 | 154/52.2 | 13.3 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.28 Cr. | 13.3 | 17.4/4.42 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 51.3 Cr. | 68.0 | 148/63.0 | 32.5 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 7.07 Cr. | 23.6 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 106 Cr. | 24.5 | 42.0/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 18.7 Cr. | 36.8 | 46.0/22.1 | 54.9 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 199 Cr. | 346 | 418/210 | 20.5 | 110 | 1.30 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 33.3 Cr. | 56.6 | 62.6/6.38 | 85.4 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 74,429 Cr. | 1,270 | 1,593/958 | 20.4 | 527 | 0.35 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 173 Cr. | 278 | 307/121 | 28.1 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,089 Cr. | 218 | 265/146 | 18.4 | 60.5 | 1.15 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 57.4 Cr. | 44.0 | 86.1/43.0 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 9,234 Cr. | 2,257 | 2,327/1,004 | 98.9 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 8.06 Cr. | 1.22 | 1.45/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 439 Cr. | 57.3 | 77.7/37.5 | 33.0 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 13.0 Cr. | 22.2 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 84.8 Cr. | 3.60 | 6.25/2.87 | 128 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 62,106 Cr. | 29,264 | 30,521/22,520 | 48.3 | 1,657 | 1.40 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,145 Cr. | 677 | 722/381 | 26.9 | 205 | 0.44 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 155 Cr. | 55.5 | 75.8/37.0 | 22.4 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,230 Cr. | 814 | 859/440 | 58.0 | 0.12 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 23,998 Cr. | 1,478 | 1,537/403 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 918 Cr. | 281 | 325/122 | 33.3 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 9.38 % | 233 % | 2.00 | |
| Venus Remedies Ltd | 410 Cr. | 307 | 430/280 | 18.6 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,085 Cr. | 720 | 950/403 | 102 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,013 Cr. | 1,418 | 1,923/1,232 | 31.1 | 735 | 0.71 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,15,389 Cr. | 3,405 | 3,591/2,249 | 66.3 | 222 | 0.82 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,437 Cr. | 264 | 317/181 | 46.0 | 44.8 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,867 Cr. | 19.9 | 27.9/11.0 | 58.8 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 29,741 Cr. | 1,168 | 1,360/585 | 122 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,784 Cr. | 128 | 169/80.0 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,46,540 Cr. | 1,861 | 1,960/1,252 | 39.8 | 288 | 0.73 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,915 Cr. | 675 | 886/322 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 1,982 Cr. | 235 | 398/118 | 33.8 | 70.6 | 0.17 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 363 Cr. | 1,202 | 1,750/522 | 17.9 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,526 Cr. | 769 | 960/313 | 131 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,403 Cr. | 175 | 241/91.8 | 207 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,075 Cr. | 6,112 | 7,600/4,606 | 33.4 | 298 | 2.73 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,506 Cr. | 2,120 | 2,977/1,306 | 40.3 | 229 | 0.75 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,781 Cr. | 5,287 | 5,850/4,637 | 38.8 | 324 | 1.13 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 226 Cr. | 63.9 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 22,295 Cr. | 4,874 | 6,453/3,950 | 36.4 | 820 | 0.72 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 248 Cr. | 202 | 348/190 | 13.6 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,598 Cr. | 427 | 491/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 9,189 Cr. | 1,811 | 1,854/702 | 77.2 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,569 Cr. | 13,702 | 18,100/5,021 | 66.5 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 868 Cr. | 39.0 | 56.5/26.2 | 80.9 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,931 Cr. | 1,392 | 1,639/801 | 12.8 | 399 | 0.68 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,213 Cr. | 76.9 | 101/38.6 | 32.1 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,312 Cr. | 294 | 359/126 | 38.5 | 50.3 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 180 Cr. | 114 | 145/85.2 | 19.1 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 551 Cr. | 154 | 177/97.9 | 174 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 1,01,655 Cr. | 2,228 | 2,312/1,308 | 38.7 | 343 | 0.36 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,549 Cr. | 772 | 980/498 | 16.0 | 319 | 0.23 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 31,621 Cr. | 587 | 593/359 | 134 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 922 Cr. | 889 | 961/381 | 26.8 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 205 Cr. | 96.0 | 129/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,039 Cr. | 216 | 370/198 | 19.6 | 103 | 1.39 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 523 Cr. | 324 | 470/298 | 37.2 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 17,156 Cr. | 1,079 | 1,310/531 | 60.3 | 373 | 0.46 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,301 Cr. | 1,819 | 2,030/1,474 | 46.3 | 207 | 0.67 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,699 Cr. | 640 | 820/270 | 63.5 | 74.4 | 0.78 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 41,448 Cr. | 1,633 | 1,709/1,052 | 66.5 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,406 Cr. | 410 | 538/331 | 24.0 | 283 | 1.22 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 156 Cr. | 28.6 | 32.6/14.3 | 2.84 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 615 Cr. | 104 | 186/86.2 | 6.02 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 3,052 Cr. | 332 | 417/286 | 137 | 118 | 0.45 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,701 Cr. | 381 | 465/260 | 64.0 | 97.6 | 0.31 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 2,045 Cr. | 2,398 | 3,379/1,293 | 87.1 | 355 | 0.25 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,458 Cr. | 445 | 504/278 | 52.5 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 14,208 Cr. | 586 | 725/382 | 29.2 | 141 | 0.26 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 44,768 Cr. | 1,586 | 1,831/767 | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 38,555 Cr. | 2,274 | 3,088/1,825 | 48.1 | 98.7 | 1.41 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 29,812 Cr. | 1,811 | 2,221/1,586 | 27.0 | 557 | 1.10 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 8,147 Cr. | 500 | 659/390 | 25.7 | 141 | 1.00 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 18,332 Cr. | 1,347 | 1,594/809 | 52.8 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,15,937 Cr. | 1,389 | 1,421/1,104 | 21.7 | 369 | 0.58 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,220 Cr. | 269 | 308/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,21,785 Cr. | 1,507 | 1,702/1,242 | 26.4 | 351 | 0.86 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 19,781 Cr. | 2,600 | 2,641/1,221 | 40.1 | 334 | 0.19 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 439 Cr. | 173 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,689 Cr. | 161 | 180/92.2 | 19.1 | 96.0 | 0.31 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 96.9 Cr. | 59.6 | 92.0/53.4 | 183 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 42,327 Cr. | 353 | 396/244 | 29.3 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,992 Cr. | 2,072 | 2,326/1,060 | 48.6 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 197 Cr. | 122 | 158/89.0 | 25.9 | 43.2 | 0.98 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 189 Cr. | 80.0 | 113/73.2 | 246 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 15,902 Cr. | 6,359 | 8,140/4,050 | 124 | 272 | 0.38 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,079 Cr. | 716 | 863/556 | 43.8 | 103 | 0.64 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 244 Cr. | 115 | 145/69.9 | 11.7 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 65,603 Cr. | 5,483 | 6,440/4,407 | 30.2 | 961 | 0.73 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,604 Cr. | 1,049 | 1,304/753 | 32.4 | 249 | 1.05 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 766 Cr. | 1,342 | 1,754/960 | 11.2 | 724 | 0.86 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 37,963 Cr. | 3,044 | 3,486/1,988 | 43.4 | 294 | 1.18 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,911 Cr. | 350 | 571/334 | 26.7 | 120 | 1.46 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,144 Cr. | 450 | 635/420 | 33.1 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,379.37 Cr | 1,181.13 | 55.46 | 184.74 | 0.31% | 16.14% | 16.48% | 6.30 |
